De la contraception a la substitution

De la contraception a la substitutio

Le traitement substitutif de la ménopause en 2011: Place de l'hormonothérapie très faiblement dosée ou « ultra-low-dose therapy »

Les recommandations les plus récentes concernant le traitement hormonal de substitution de la ménopause soulignent l’importance de prescrire la dose efficace la plus faible possible. Plusieurs études ont démontré que les associations très faiblement dosées (« ultralow-dose ») combinant 0,5 mg d’œstradiol et un progestatif sont suffisantes pour traiter les troubles vasomoteurs liés à la ménopause et pour prévenir la perte osseuse sans augmenter le risque d’adénocarcinome de l’endomètre

Expansive benign lesions: treatment by laser.

peer reviewedSubmucous fibroids, polyps and dysfunctional bleeding are responsible for meno-metrorrhagia in women over 40 years of age. The authors describe the technique of hysteroscopic myomectomy and endometrial ablation using the Nd-YAG laser and the advantages of the preoperative use of GnRH agonist therapy. They report their results in a series of 746 patients treated for meno-metrorrhagia (366 cases of myomectomy and 380 cases of endometrial ablation)

Severe endometriosis involving the urogenital system

This chapter describes two forms of endometriosis involving the urogenital system. It should be pointed out that the prevalence of both ureteral and bladder endometriosis has dramatically and significantly increased in recent years. According to the findings of one our of last studies, environmental toxins could be responsible for this increase